Our Therapeutic Innovation team

This is our drug discovery engine, uniting the strength of our network of world-class biology with cutting-edge technology platforms and small molecule and antibody drug discovery expertise. We are a single organisation with multiple sites embedded in leading UK academic and biotech centres.

Image of Hamish Ryder

Hamish Ryder

Chief Executive Officer, Therapeutic Innovation

Image of Steve Wedge

Steve Wedge

Chief Scientific Officer, Therapeutic Innovation

IWD Rachel Grimley quote

Rachel Grimley

Senior Vice President of Drug Discovery, Cancer Research Horizons

A photo of Kevin Doyle, Vice President of Medicinal Chemistry and DMPK

Kevin Doyle

Vice President of Medicinal Chemistry and DMPK

Image of Stuart Farrow

Stuart Farrow

Vice President of Biosciences, Cancer Research Horizons

Image of Neil Jones

Neil Jones

Vice President of Portfolio Generation

Image of Jennifer McKelvie

Jennifer McKelvie

Vice President of Operations

Our associate directors

Agnes Martin, AD

Agnes Martin

Associate Director, Mechanistic Pharmacology

Nick Tribble, AD

Nick Tribble

Associate Director, Antibody Discovery

Our group leaders

Stuart Haynes

Group Leader, Antibody Discovery

Gillian Farnie

Group Leader, Biosciences

Becky Harris

Group Leader, Biosciences

Sofia Lourenco

Group Leader, Biosciences

Craig Mackay

Group Leader, Biosciences

Hilary Sandig

Group Leader, Biosciences

Fredrik Svensson

Group Leader, Computational Chemistry

David Walter

Group Leader, Functional Genomics Centre

Louise Tonkin

Group Leader, Mechanistic Pharmacology

Verity Sabin

Group Leader, Medicinal Chemistry

John Taylor

Group Leader, Medicinal Chemistry

Edward Wheatley

Group Leader, Protein Science

Andrew Turnbull

Group Leader, Structural Biology

Looking to collaborate with us in drug discovery?

We're looking for the right partnerships to accelerate the discovery of the next generation of cancer medicines.

Contact us